MC
ABBV icon

Mirabaud & Cie’s AbbVie ABBV Stock Holding History

Mirabaud & Cie’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
8,766
+176
+2% +$37.9K 0.89% 22
2026
Q1 		$1.87M Buy
8,590
+3,490
+68% +$774K 0.76% 22
2025
Q4 		$1.17M Hold
5,100
– – 0.38% 34
2025
Q3 		$1.18M Hold
5,100
– – 0.38% 39
2025
Q2 		$947K Hold
5,100
– – 0.3% 45
2025
Q1 		$1.07M Hold
5,100
– – 0.36% 41
2024
Q4 		$906K Buy
+5,100
New +$938K 0.29% 42

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Mirabaud & Cie's ABBV Position: Q2 2026 in Review

Mirabaud & Cie increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $37.9K and bringing the position to 8,766 shares worth $2.21M. The position accounts for 0.89% of the portfolio, ranked #22.

Mirabaud & Cie first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mirabaud & Cie held 8,766 shares of AbbVie worth $2.21M as of Q2 2026.
  • Mirabaud & Cie bought 176 AbbVie shares in Q2 2026, an estimated $37.9K.
  • AbbVie made up 0.89% of Mirabaud & Cie's portfolio in Q2 2026, its #22 holding.
  • Mirabaud & Cie first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mirabaud & Cie's 13F filing for Q2 2026, filed 8 Jul 2026.